https://emvcapital.com/portfolio/pds-biotechnology/
PDS Biotechnology - EMV Capital
Nov 28, 2024 - PDS Biotechnology is listed on NASDAQ. PDS Biotech was established with the goal of harnessing the power of T cells to address some of the most devastating...
pds biotechnologyemvcapital
https://www.ad-hoc-news.de/boerse/news/ueberblick/pds-biotechnology-aktie-alles-auf-tempo/69140964
PDS Biotechnology Aktie: Alles auf Tempo!
PDS Biotechnology priorisiert die beschleunigte Marktzulassung von PDS0101 durch eine angepasste klinische Studie, trotz aktueller Verluste und eines volatilen...
pds biotechnologyaktieallesauftempo
https://stocksavvy.ai/filings/pds-biotechnology-corp-nasdaq/pds-biotechnology-secures-6m-financing-and-refinances-debt
PDS Biotechnology Secures $6M Financing and Refinances Debt
SEC 8-K filing: PDS Biotechnology has entered into a $6 million securities purchase agreement and initiated an at-the-market offering program while retiring...
pds biotechnologysecuresfinancingrefinancesdebt
https://www.home.saxo/markets/stocks/pdsb-xnas
PDS Biotechnology Corp. stock | Saxo
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States.
pds biotechnologycorpstocksaxo
https://www.einpresswire.com/article/530088317/pds-biotechnology-appoints-renowned-oncologist-otis-brawley-m-d-to-its-board-of-directors
PDS Biotechnology Appoints Renowned Oncologist Otis Brawley, M.D. to its Board of Directors
Nov 5, 2020 - PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on
https://middleeastnewsdigest.com/article/811191533-pds-biotechnology-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Middle East News...
Middle East News Digest is an online news publication focusing on the Middle East: Your daily news update on the Middle East